Version history
What has changed on this site, when, and why.
Change log
| Date | Version | Change |
|---|---|---|
| July 12, 2026 | 1.2 | Brand pricing corrected against LillyDirect and NovoCare. Prior figures ($349-$549 Zepbound) were stale after the manufacturers' late-2025 price cuts. |
| July 11, 2026 | 1.1 | NexLife pricing matrix rebuilt from published program pages: 6 programs x 4 plan lengths. Four arithmetic corrections applied where the provider's own marketing card disagreed with its own plan totals. |
| July 6, 2026 | 1.0 | Provider dataset rebuilt on a dated 18-provider capture. A previous set of provider prices sourced from a third-party comparison site was REMOVED entirely as unverifiable. |
Why we publish this
A site that silently edits its numbers is asking you to trust it. A site that shows you what it changed and why is giving you something you can actually check. Two of the three entries above are us correcting our own published errors.
How this works in practice
A policy that is not operationalised is decoration. Here is what ours actually changes about the pages you read.
Every price carries a status. Verified means we hold a dated capture of the provider's own page. Reported — pending verification means a provider or third party reports it and we have not captured it ourselves. Evaluation in progress means we are not asserting it. We do not upgrade a price to Verified because a comparison site published it — sites in this category contradict each other routinely, and a number repeated by three affiliate blogs is still one unverified number.
Every medical claim traces to a primary source. FDA labels and guidance for regulatory status; PubMed-indexed randomised trials for efficacy; ClinicalTrials.gov for trial design. Reddit and patient forums are never used as evidence of price, safety, efficacy or legitimacy — they may be described as anecdotal sentiment, labelled as such. Animal research is never presented as proof of a human clinical effect.
Every ranking shows its arithmetic. Where a provider we have a commercial relationship with ranks well, the calculation that produced that result is printed on the page. If the arithmetic is wrong, you can see that it is wrong, and tell us.
Commercial relationships and what they do not buy
The publisher and certain principals have financial relationships with some of the telehealth providers listed on this site, and we may earn a commission when readers use certain links. That is how this publication is funded, and we state it in the footer of every page rather than burying it.
What compensation does not do: it does not change a score, a rank, an inclusion decision, or a negative finding. Providers cannot pay for placement, cannot suppress an accurate criticism, and cannot review their own page before publication. Where a commercially-related provider loses a category, we say so — a comparison in which one provider wins everything is an advertisement, and the fastest way to tell the difference is to look for the losses.
Corrections
We publish prices in a market that changes them frequently, and we will get things wrong. When we do, we correct the page, date the correction, and say what changed — we do not quietly edit a number and pretend it was always right. Both readers and providers can submit corrections with evidence, through the same process and to the same standard.
Our own record so far includes removing a set of provider prices we had sourced from a third-party comparison site and could not substantiate, and correcting brand-pricing figures that had gone stale after a manufacturer price cut. Both corrections made the site less flattering to conclusions we had already published. That is the point.